Immunoglobulins for preventing hepatitis A-Reference-Cited by-同舟云学术

Immunoglobulins for preventing hepatitis A

Published:2009-04-15 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Liu Jian Ping¹,Nikolova Dimitrinka²,Fei Yutong¹

Affiliation:

1. Beijing University of Chinese Medicine; Centre for Evidence-Based Chinese Medicine; 11 Bei San Huan Dong Lu, Chaoyang District Beijing China 100029

2. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

Publisher

Wiley

Subject

Pharmacology (medical)

Reference69 articles.

1. Prophylactic gamma globulin for prevention of endemic hepatitis. Effects of US gamma globulin upon the incidence of viral hepatitis and other infectious diseases in US Soldiers abroad;Anonymous;Archives of Internal Medicine,1971

2. Endemic viral hepatitis in US soldiers: causative factors and the effect of prophylactic gamma globulin;Conrad;Canadian Medical Association Journal,1972

3. Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin;Conrad;Journal of Infectious Diseases,1987

4. Viral hepatitis in United States soldiers stationed in Korea, 1967-1970: prophylactic efficacy of gamma globulin;Smetana;Bulletin of the New York Academy of Medicine,1976

5. [Effectiveness of preseason serum prevention of hepatitis A using different doses of 10% commercial immunoglobulin];Gorbunov;Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii,1981

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Anti‐Hepatitis A Antibody Pharmacokinetics in Healthy Australian Subjects Receiving Standard or Weight‐Based Dosing of Polyvalent Immunoglobulin;The Journal of Clinical Pharmacology;2024-07-05

2. Hepatitis A virus infection;Nature Reviews Disease Primers;2023-09-28

3. Hyperimmune Globulins for the Management of Infectious Diseases;Viruses;2023-07-13

4. Hepatitis A Virus;Viral Infections of Humans;2023

5. Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure;Expert Opinion on Drug Metabolism & Toxicology;2020-05-03